logo
Select company
Select metric
$ 8.8MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
40
Sector
77
Industry
43
History
67
$ 2.69Close
$ 1.61 - $ 9.01 52-Week Range
Ticker Information

Ticker

SNYR

Company Name

SYNERGY CHC CORP

Sector

Healthcare

Industry

Medical Distribution

Exchange

NASDAQ

SYNERGY CHC CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SNYR - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 133.33K$ 8.67M$ 8.8M
3/31/2025$ 133.33K$ 6.47M$ 6.61M
12/31/2024$ 133.33K$ 6.33M$ 6.47M
12/31/2023$ 33.33K$ 10.81M$ 10.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SYNERGY CHC CORP's latest trailing twelve months (TTM) EBITDA stands at $ 10.84M.
  • Over the past 5 years, SYNERGY CHC CORP's average EBITDA has been $ 8.18M.
  • The median EBITDA for SYNERGY CHC CORP during this period was $ 7.7M
  • SYNERGY CHC CORP reached its highest EBITDA over the past 5 years at $ 10.84M.
  • The lowest EBITDA recorded by SYNERGY CHC CORP in the same timeframe $ 6.47M

SYNERGY CHC CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
MRSN : MERSANA THERAPEUTICS INC $ -65.59MCCEL : CRYO CELL INTERNATIONAL INC $ 5.16MCOSM : COSMOS HEALTH INC $ -12.84MRVP : RETRACTABLE TECHNOLOGIES INC $ -829.42KPOCI : PRECISION OPTICS CORPORATION INC $ -5.34MXFOR : X4 PHARMACEUTICALS INC $ -88.88MGBIO : GENERATION BIO CO $ -67.79MNEPH : NEPHROS INC $ 1.49MDRIO : DARIOHEALTH CORP $ -37.69MVVOS : VIVOS THERAPEUTICS INC $ -13.55M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for SYNERGY CHC CORP is calculated as follows: EBIT [ $ 10.81M ] + DepAmor [ $ 33.33K ]
(=) EBITDA [ $ 10.84M ]

SNYR - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ 6.47M

Minimum

Dec 31, 2024

$ 10.84M

Maximum

Dec 31, 2023

$ 8.18M

Average

$ 7.7M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M